Research graph
References from Survival Outcomes of Gemcitabine–Cisplatin–S‐1 Versus Gemcitabine–Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s0140-6736(13)61903-0
10.1016/s0140-6736(13)61903-0 · External reference
10.1056/nejmoa0908721
10.1056/nejmoa0908721 · External reference
10.1093/annonc/mdz402
10.1093/annonc/mdz402 · External reference
10.1002/jhbp.1219
10.1002/jhbp.1219 · External reference
10.1007/s00423-025-03630-x
10.1007/s00423-025-03630-x · External reference
10.1002/ags3.12713
10.1002/ags3.12713 · External reference
10.1007/s00595-024-02912-z
10.1007/s00595-024-02912-z · External reference
10.1016/j.hpb.2018.12.001
10.1016/j.hpb.2018.12.001 · External reference
10.1002/jhbp.1437
10.1002/jhbp.1437 · External reference
10.1245/s10434-015-4768-9
10.1245/s10434-015-4768-9 · External reference
10.1007/s00595-020-02031-5
10.1007/s00595-020-02031-5 · External reference
10.1002/ags3.12710
10.1002/ags3.12710 · External reference
10.1002/ags3.12691
10.1002/ags3.12691 · External reference
10.1056/evidoa2200015
10.1056/evidoa2200015 · External reference
10.1016/s0140-6736(23)00727-4
10.1016/s0140-6736(23)00727-4 · External reference
10.1097/js9.0000000000001540
10.1097/js9.0000000000001540 · External reference
